Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin
Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin
A variety of adjuvants with the potential for use with experimental human vaccines were used for immunisation of mice, in an attempt to augment the humoral immune response to a multiple antigen peptide (MAP) containing a protective epitope from the sero-subtype specific class 1 porin protein of Neisseria meningitidis, in tandem with a Th-cell epitope. Surface plasmon resonance showed that combinations of the immunomodulators pluronic block co-polymer, muramyl dipeptide and monophosphoryl lipid A (MPL), increased the magnitude and avidity of the immune response in comparison with both Al(OH)3 and Freund-type adjuvants. In addition, the incorporation of MPL was essential for the induction of a broad distribution of antibody isotypes. The antibodies induced recognised the native protein in meningococcal outer membranes in a subtype-specific manner. The formulations containing these multiple immunomodulators which have already been used in human phase I/II trials with experimental vaccines, are candidates for inclusion in future human vaccines based on synthetic peptides containing defined, protective epitopes.
meningococci, adjuvant, peptide vaccine
131-9
Christodoulides, Myron
eba99148-620c-452a-a334-c1a52ba94078
Rattue, Elizabeth
de38f3e5-55ca-438e-a67f-4782af1ea671
Heckels, John E.
fcfcfafe-5ca8-4728-9c5e-cb67f9af7e31
20 August 1999
Christodoulides, Myron
eba99148-620c-452a-a334-c1a52ba94078
Rattue, Elizabeth
de38f3e5-55ca-438e-a67f-4782af1ea671
Heckels, John E.
fcfcfafe-5ca8-4728-9c5e-cb67f9af7e31
Christodoulides, Myron, Rattue, Elizabeth and Heckels, John E.
(1999)
Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin.
Vaccine, 18 (1-2), .
(doi:10.1016/S0264-410X(99)00190-5).
(PMID:10501243)
Abstract
A variety of adjuvants with the potential for use with experimental human vaccines were used for immunisation of mice, in an attempt to augment the humoral immune response to a multiple antigen peptide (MAP) containing a protective epitope from the sero-subtype specific class 1 porin protein of Neisseria meningitidis, in tandem with a Th-cell epitope. Surface plasmon resonance showed that combinations of the immunomodulators pluronic block co-polymer, muramyl dipeptide and monophosphoryl lipid A (MPL), increased the magnitude and avidity of the immune response in comparison with both Al(OH)3 and Freund-type adjuvants. In addition, the incorporation of MPL was essential for the induction of a broad distribution of antibody isotypes. The antibodies induced recognised the native protein in meningococcal outer membranes in a subtype-specific manner. The formulations containing these multiple immunomodulators which have already been used in human phase I/II trials with experimental vaccines, are candidates for inclusion in future human vaccines based on synthetic peptides containing defined, protective epitopes.
This record has no associated files available for download.
More information
Published date: 20 August 1999
Keywords:
meningococci, adjuvant, peptide vaccine
Identifiers
Local EPrints ID: 193813
URI: http://eprints.soton.ac.uk/id/eprint/193813
PURE UUID: 47c81e19-c82c-4d0f-b3bc-f60b5d4f4285
Catalogue record
Date deposited: 20 Jul 2011 13:38
Last modified: 15 Mar 2024 02:39
Export record
Altmetrics
Contributors
Author:
Elizabeth Rattue
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics